Researchers presented a study at the American Association for Cancer Research's Annual Meeting, April 3, 2017 in Washington, D.C., that examined the effect pesticide exposure plays in developing cancer, Live Science reports.
GI & Endoscopy
The New York City-based Crohn's & Colitis Foundation and the American Gastroenterological Association, in collaboration with New York City-based Pfizer, are developing a program to improve patient-provider communication on inflammatory bowel disease.
Here are six updates on GI companies:
Truc Trinh, MD, is a gastroenterologist with Arlington-based Gastroenterology Center of Northern Virginia.
Osaka, Japan-based Takeda Pharmaceuticals entered into a strategic collaboration with Teaneck, N.J.-based NuBiyota for its microbial ecosystem therapeutic products.
Advertisement
A study in Inflammatory Bowel Diseases found communication on quality of life outcomes is poor between ulcerative colitis patients and their gastroenterologists.
A study published in the Journal of Clinical Investigation examined peroxisome proliferator-activated receptor y's transcription role in liver tumorigenesis, which was previously unknown.
A study published in Science examined reoviruses' effect on immune systems and dietary antigens.
Seth Gross, MD, is the chief of gastroenterology at New York City-based NYU Langone Medical Center.
New York City-based Pfizer awarded UC Riverside associate professor Declan McCole, MD, a two-year, $150,000 grant to support his inflammatory bowel disease research.